Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.1 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |